Why kidney failure causes hyperkalaemia and what the nurse watches for

How the kidneys normally keep potassium in balance

Most potassium sits inside cells, and only a small amount circulates in the blood. The body keeps that small blood level steady mainly by secreting potassium in the distal part of the nephron and passing it out in urine. Because the blood level is so narrow, even a modest daily surplus that is not excreted can raise serum potassium in a meaningful way.

In chronic kidney disease, the remaining nephrons adapt by secreting more potassium each. That adaptation usually keeps the level normal until kidney failure is advanced or intake is excessive. This explains a common exam pattern: a client with earlier-stage disease may have a normal potassium, then develop hyperkalaemia when function declines further or when a new medicine or diet change tips the balance.

The extra factors that push potassium higher

Several medicines reduce potassium excretion and become more dangerous when the kidneys are already struggling. These include ACE inhibitors, angiotensin receptor blockers, potassium-sparing diuretics and mineralocorticoid receptor antagonists, NSAIDs and trimethoprim. On a question stem, a client with kidney disease who has just started or increased one of these is a cue to anticipate a rising potassium.

Intake matters too. Potassium supplements, salt substitutes that use potassium chloride and potassium-rich foods add to a load the kidneys cannot clear. Metabolic acidosis, which often accompanies kidney failure, shifts potassium out of cells into the blood. So a client may have a higher serum potassium without any extra intake, simply because acid-base balance has worsened.

Why the heart is the organ at risk

Potassium sets the resting electrical state of heart muscle cells. As the serum level climbs, the ECG tends to change in a recognised sequence: tall, peaked T waves and a lengthening PR interval, then loss of P waves and widening of the QRS complex. At the extreme, the tracing can become a sine wave pattern that degenerates into ventricular fibrillation or asystole.

Hyperkalaemia is often asymptomatic until an arrhythmia develops. Some clients report palpitations, weakness, nausea or a slow, weak pulse, but many feel nothing. This is why the nurse cannot use symptoms to judge safety. A high result in a client with kidney failure needs a cardiac assessment and prompt reporting, even when the client says they feel well.

Expected versus concerning trends and nursing actions

A stable, mildly raised potassium in a client with known advanced kidney disease may be managed with diet review and medicine adjustment by the prescriber. A rising trend, a new peaked T wave, a widened QRS or a new arrhythmia is a different situation. Those findings call for cardiac monitoring, urgent notification and preparation for treatment under the local hyperkalaemia protocol.

Practical nursing steps include reviewing the medicine list for potassium-raising drugs, asking about salt substitutes and supplements, and checking whether recent bloods suggest worsening acidosis or kidney function. Teaching focuses on the individual dietary plan from the renal team, avoiding salt substitutes unless approved, and keeping laboratory appointments. Clients should know which symptoms to report rather than waiting for the next scheduled test.

Work a hypothetical scenario

Imagine a hypothetical client with advanced chronic kidney disease whose ACE inhibitor dose was recently increased. They mention using a salt substitute at home. The potassium result is high, and the monitor shows new peaked T waves. Options include teaching about low-potassium foods, rechecking the level tomorrow, or reporting the result and ECG change immediately while maintaining cardiac monitoring.

Immediate reporting with continuous cardiac monitoring is the strongest choice because the ECG shows the heart is already affected. Diet teaching is useful but can wait until the client is safe. Waiting for a repeat test ignores an evolving arrhythmia risk. The scenario rewards linking the mechanism, a drug plus extra intake in failing kidneys, to the cardiac priority.

Sources and further reading

MSD Manual Professional: Hyperkalemia. Reduced excretion in kidney disease, potassium-raising medicines, acidosis shift, intake sources and the ECG progression.

MSD Manual Professional: Chronic kidney disease. Renal adaptation keeping potassium normal until failure is advanced; diet restriction, salt substitutes and acidosis correction.

MedlinePlus: High potassium level. Kidney and blood pressure medicine causes, often absent symptoms, palpitations, weakness and slow pulse.